A comparative study on the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension

被引:7
作者
Hamada, Toshihiro [1 ]
Kuwabara, Masanari [2 ]
Watanabe, Arisa [1 ]
Mizuta, Einosuke [3 ]
Ohtahara, Akira [3 ]
Omodani, Hiroki [4 ]
Watanabe, Masashi [5 ]
Nakamura, Hiroki [6 ]
Hirota, Yutaka [7 ]
Miyazaki, Satoshi [8 ]
Kato, Masahiko [9 ]
Ogino, Kazuhide [10 ]
Kosaka, Hiroki [11 ]
Haruaki, Ninomiya [12 ]
Taniguchi, Shin-ichi [1 ]
Yamamoto, Kazuhiro [9 ]
Kotake, Hiroshi [13 ]
Hisatome, Ichiro [2 ]
机构
[1] Tottori Univ, Fac Med, Dept Reg Med, Yonago, Tottori 6838503, Japan
[2] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut, Yonago, Tottori 6838503, Japan
[3] Sanin Rosai Hosp, Dept Cardiovasc Med, Yonago, Tottori, Japan
[4] Omodani Clin, Div Cardiovasc Med, Yonago, Tottori, Japan
[5] Watanabe Clin, Div Cardiovasc Med, Sakaiminato, Japan
[6] Nakamura Clin, Tottori, Japan
[7] Tomimasu Surg & Primary Care Clin, Yonago, Tottori, Japan
[8] Nojima Hosp, Div Cardiol, Kurayoshi, Japan
[9] Tottori Univ, Fac Med, Div Mol Med & Therapeut, Yonago, Tottori 6838503, Japan
[10] Tottori Univ Hosp, Ctr Clin Residency Program, Yonago, Tottori, Japan
[11] Tottori Red Cross Hosp, Div Internal Med, Tottori, Japan
[12] Tottori Univ, Fac Med, Dept Biochem Regulat, Yonago, Tottori 6838503, Japan
[13] Kotake Clin, Div Cardiovasc Med, Yonago, Tottori, Japan
关键词
HOMA-R; hydrochlorothiazide; losartan; serum uric acid; telmisartan; URIC-ACID; URATE LEVELS; BENZBROMARONE; COMBINATION; LOSARTAN; THERAPY;
D O I
10.3109/10641963.2013.810228
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: Long-term effects of a low-dose hydrochlorothiazide (HCTZ) with losartan (LOS) on uric acid (UA) metabolism as well as glucose metabolism have been studied in hypertensive patients in comparison with those of a low-dose HCTZ with telmisartan (TEL). Method: Fifty-nine hypertensive patients were allocated to a combination therapy with either losartan (50 mg/day)/HCTZ (12.5 mg/day) (LOS + HCTZ group: n = 37) or telmisartan (40 mg/day)/HCTZ (12.5 mg/day) (TEL + HCTZ group: n = 22), respectively. Before and 1 year after the treatment, blood pressure and biochemical parameters of blood and urine were evaluated. Results: Both systolic and diastolic blood pressures significantly decreased in two groups, without any statistical differences among them. LOS + HCTZ caused no changes in the serum UA level or the ratio of UA clearance to creatinine clearance (CUA/Ccr), whereas TEL + HCTZ significantly increased the serum UA level and reduced CUA/Ccr. LOS + HCTZ did not influence CUA/Ccr in patients with their serum UA below 5.4 mg/dl, while LOS + HCTZ significantly increased CUA/Ccr in patients with their serum UA above 5.5 mg/dl. TEL + HCTZ significantly reduced CUA/Ccr in patients with their serum UA below and above 5.4 mg/dl to increase serum UA level significantly. Neither combination therapies caused any changes in fasting plasma glucose, HbA1c and HOMA-R. In patients with their serum UA level above 5.4 mg/dl, TEL + HCTZ increased HOMA-R, whereas LOS + HCTZ did not. Conclusions: LOS + HCTZ did not influence UA metabolism as well as glucose metabolism, likely because of inhibitory action of losartan on URAT1, although TEL + HCTZ were accompanied with impairment of the UA metabolism and glucose metabolism.
引用
收藏
页码:251 / 257
页数:7
相关论文
共 16 条
[1]   Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study [J].
Choi, Hyon K. ;
Soriano, Lucia Cea ;
Zhang, Yuqing ;
Garcia Rodriguez, Luis A. .
BRITISH MEDICAL JOURNAL, 2012, 344
[2]   Molecular identification of a renal urate-anion exchanger that regulates blood urate levels [J].
Enomoto, A ;
Kimura, H ;
Chairoungdua, A ;
Shigeta, Y ;
Jutabha, P ;
Cha, SH ;
Hosoyamada, M ;
Takeda, M ;
Sekine, T ;
Igarashi, T ;
Matsuo, H ;
Kikuchi, Y ;
Oda, T ;
Ichida, K ;
Hosoya, T ;
Shimokata, K ;
Niwa, T ;
Kanai, Y ;
Endou, H .
NATURE, 2002, 417 (6887) :447-452
[3]   Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT1) in hypertensive patients [J].
Hamada, Toshihiro ;
Ichica, Kimiyoshi ;
Hosoyamada, Makoto ;
Mizuta, Einosuke ;
Yanagihara, Kiyotaka ;
Sonoyama, Kazuhiko ;
Sugihara, Shinobu ;
Igawa, Osamu ;
Hosoya, Tatsuo ;
Ohtahara, Akira ;
Shigamasa, Chiaki ;
Yamamoto, Yasutaka ;
Ninomiya, Haruaki ;
Hisatome, Ichiro .
AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (10) :1157-1162
[4]  
Hamada T, 2010, ARZNEIMITTEL-FORSCH, V60, P71, DOI 10.1055/s-0031-1296251
[5]   Effects of Combined Antihypertensive Therapy with Losartan/Hydrochlorothiazide on Uric Acid Metabolism [J].
Hosoya, Tatsuo ;
Kuriyama, Satoru ;
Yoshizawa, Takeo ;
Kobayashi, Akimitsu ;
Otsuka, Yasushi ;
Ohno, Iwao .
INTERNAL MEDICINE, 2012, 51 (18) :2509-2514
[6]   Effects of Benzbromarone and Allopurinol on Adiponectin In Vivo and In Vitro [J].
Inokuchi, T. ;
Tsutsumi, Z. ;
Takahashi, S. ;
Ka, T. ;
Yamamoto, A. ;
Moriwaki, Y. ;
Masuzaki, H. ;
Yamamoto, T. .
HORMONE AND METABOLIC RESEARCH, 2009, 41 (04) :327-332
[7]   Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter [J].
Iwanaga, Takashi ;
Sato, Masanobu ;
Maeda, Tomoji ;
Ogihara, Toshio ;
Tamai, Ikumi .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01) :211-217
[8]   One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors [J].
Kita, Toshihiro ;
Yokota, Naoto ;
Ichiki, Yoshinari ;
Ayabe, Takao ;
Etoh, Takuma ;
Tamaki, Noboru ;
Kato, Johji ;
Eto, Tanenao ;
Kitamura, Kazuo .
HYPERTENSION RESEARCH, 2010, 33 (04) :320-325
[9]   Comparison of Therapies Between Fixed-Dose Telmisartan/Hydrochlorothiazide and Losartan/Hydrochlorothiazide in Patients With Mild to Moderate Hypertension [J].
Minami, Junichi ;
Furukata, Satoshi ;
Ishimitsu, Toshihiko ;
Matsuoka, Hiroaki .
INTERNATIONAL HEART JOURNAL, 2009, 50 (01) :85-93
[10]  
Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15